Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc. (HEPA) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 16 transactions totaling $247.4K, demonstrating a bullish sentiment with $247.4K in net insider flow. The most recent transaction on Nov 27, 2023 involved a purchase of 2,500 shares valued at $7.6K.
HEPA Insider Activity Summary
Who Is Buying HEPA Stock?
No significant insider buying has been recorded for HEPA in the recent period.
Who Is Selling HEPA Stock?
No significant insider selling has been recorded for HEPA in the recent period.
Is Hepion Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for HEPA is bullish with an Insider Alignment Score of 100/100 and a net flow of $247.4K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
HEPA Frequently Asked Questions
Understanding HEPA Insider Activity
Insider trading at Hepion Pharmaceuticals, Inc. (HEPA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading HEPA stock, having executed 16 transactions in the past 90 days. The most active insider is Robert T. Foster (Executive), who has made 4 transactions totaling $97.1K.
Related Tools
Track Hepion Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at HEPA file new Form 4 transactions